Lotus Pharmaceutical Co., Ltd. (1795.TW)
TWD 214.5
(2.14%)
TWD 214.5
(2.14%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 32.99 Billion TWD | 11.74% |
| 2022 | 29.52 Billion TWD | 39.13% |
| 2021 | 21.22 Billion TWD | 7.43% |
| 2020 | 19.75 Billion TWD | 10.24% |
| 2019 | 17.91 Billion TWD | 20.63% |
| 2018 | 14.85 Billion TWD | -5.14% |
| 2017 | 15.65 Billion TWD | 2.72% |
| 2016 | 15.24 Billion TWD | -1.66% |
| 2015 | 15.5 Billion TWD | -4.72% |
| 2014 | 16.27 Billion TWD | 713.28% |
| 2013 | 2 Billion TWD | 84.37% |
| 2012 | 1.08 Billion TWD | -3.19% |
| 2011 | 1.12 Billion TWD | -1.75% |
| 2010 | 1.14 Billion TWD | 61.36% |
| 2009 | 706.92 Million TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 34.63 Billion TWD | 1.02% |
| 2024 Q1 | 34.28 Billion TWD | 3.93% |
| 2023 Q2 | 31.67 Billion TWD | 3.35% |
| 2023 FY | 32.99 Billion TWD | 11.74% |
| 2023 Q1 | 30.64 Billion TWD | 3.81% |
| 2023 Q3 | 32.94 Billion TWD | 4.01% |
| 2023 Q4 | 32.99 Billion TWD | 0.13% |
| 2022 Q4 | 29.52 Billion TWD | 9.86% |
| 2022 Q3 | 26.87 Billion TWD | 14.06% |
| 2022 Q2 | 23.56 Billion TWD | -1.58% |
| 2022 FY | 29.52 Billion TWD | 39.13% |
| 2022 Q1 | 23.94 Billion TWD | 12.82% |
| 2021 Q3 | 20.95 Billion TWD | -2.64% |
| 2021 Q1 | 20.67 Billion TWD | 4.65% |
| 2021 FY | 21.22 Billion TWD | 7.43% |
| 2021 Q2 | 21.51 Billion TWD | 4.1% |
| 2021 Q4 | 21.22 Billion TWD | 1.29% |
| 2020 Q2 | 18.1 Billion TWD | -2.85% |
| 2020 Q1 | 18.63 Billion TWD | 3.98% |
| 2020 FY | 19.75 Billion TWD | 10.24% |
| 2020 Q4 | 19.75 Billion TWD | 6.08% |
| 2020 Q3 | 18.62 Billion TWD | 2.88% |
| 2019 FY | 17.91 Billion TWD | 20.63% |
| 2019 Q4 | 17.91 Billion TWD | -0.75% |
| 2019 Q3 | 18.05 Billion TWD | -1.98% |
| 2019 Q1 | 18.04 Billion TWD | 21.49% |
| 2019 Q2 | 18.41 Billion TWD | 2.05% |
| 2018 Q2 | 15.63 Billion TWD | 1.16% |
| 2018 Q3 | 15.69 Billion TWD | 0.38% |
| 2018 FY | 14.85 Billion TWD | -5.14% |
| 2018 Q1 | 15.45 Billion TWD | -1.3% |
| 2018 Q4 | 14.85 Billion TWD | -5.36% |
| 2017 Q3 | 15.73 Billion TWD | 0.61% |
| 2017 Q4 | 15.65 Billion TWD | -0.49% |
| 2017 FY | 15.65 Billion TWD | 2.72% |
| 2017 Q1 | 15.74 Billion TWD | 3.32% |
| 2017 Q2 | 15.64 Billion TWD | -0.69% |
| 2016 Q4 | 15.24 Billion TWD | -6.03% |
| 2016 FY | 15.24 Billion TWD | -1.66% |
| 2016 Q3 | 16.22 Billion TWD | 1.58% |
| 2016 Q2 | 15.97 Billion TWD | 2.45% |
| 2016 Q1 | 15.58 Billion TWD | 0.56% |
| 2015 Q1 | 15.91 Billion TWD | -2.17% |
| 2015 Q2 | 15.57 Billion TWD | -2.15% |
| 2015 Q3 | 15.58 Billion TWD | 0.07% |
| 2015 Q4 | 15.5 Billion TWD | -0.55% |
| 2015 FY | 15.5 Billion TWD | -4.72% |
| 2014 Q1 | 1.95 Billion TWD | -2.38% |
| 2014 Q3 | 8.93 Billion TWD | 374.34% |
| 2014 Q2 | 1.88 Billion TWD | -3.56% |
| 2014 FY | 16.27 Billion TWD | 713.28% |
| 2014 Q4 | 16.27 Billion TWD | 82.11% |
| 2013 Q2 | 1.13 Billion TWD | 2.48% |
| 2013 Q3 | 1.3 Billion TWD | 14.91% |
| 2013 Q4 | 2 Billion TWD | 53.82% |
| 2013 FY | 2 Billion TWD | 84.37% |
| 2013 Q1 | 1.1 Billion TWD | 1.79% |
| 2012 FY | 1.08 Billion TWD | -3.19% |
| 2012 Q1 | 1.32 Billion TWD | 18.25% |
| 2012 Q2 | 1.28 Billion TWD | -2.95% |
| 2012 Q3 | 1.14 Billion TWD | -11.21% |
| 2012 Q4 | 1.08 Billion TWD | -4.98% |
| 2011 Q2 | 1.21 Billion TWD | 6.3% |
| 2011 Q1 | 1.14 Billion TWD | 0.51% |
| 2011 FY | 1.12 Billion TWD | -1.75% |
| 2011 Q4 | 1.12 Billion TWD | -0.88% |
| 2011 Q3 | 1.13 Billion TWD | -7.22% |
| 2010 Q4 | 1.14 Billion TWD | 0.0% |
| 2010 FY | 1.14 Billion TWD | 61.36% |
| 2009 FY | 706.92 Million TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Grape King Bio Ltd | 15.51 Billion TWD | -112.686% |
| Standard Chem & Pharm CO., LTD. | 11.18 Billion TWD | -194.865% |
| Maywufa Company Ltd. | 2.83 Billion TWD | -1064.928% |
| ScinoPharm Taiwan, Ltd. | 11.72 Billion TWD | -181.46% |
| LIWANLI Innovation Co., Ltd. | 834.17 Million TWD | -3855.006% |
| YungShin Global Holding Corporation | 11.51 Billion TWD | -186.574% |
| PhytoHealth Corporation | 2.35 Billion TWD | -1303.592% |
| SCI Pharmtech, Inc. | 6.69 Billion TWD | -393.093% |
| Formosa Laboratories, Inc. | 13.63 Billion TWD | -141.941% |
| PharmaEssentia Corporation | 27.26 Billion TWD | -20.984% |
| Bora Pharmaceuticals Co., LTD. | 25.05 Billion TWD | -31.692% |